FdaApplication

ANDA 202187

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAUROBINDO PHARMA LTD
application_typeANDA
approval_date2014-03-06

Products (3)

ProductActive ingredientStrengthDosage form
SPIRONOLACTONESPIRONOLACTONE25MGTABLET;ORAL
SPIRONOLACTONESPIRONOLACTONE100MGTABLET;ORAL
SPIRONOLACTONESPIRONOLACTONE50MGTABLET;ORAL

3 products